Zinc and Iron Competition at Brain Level

flowchart TD
    subgraph Transport["Transporter Competition"]
        DMT1["DMT1 Transporter"]
        ZIP["ZIP8 / ZIP14 Transporters"]
        FE_IN["Iron Uptake"]
        ZN_IN["Zinc Uptake"]
    end

    FE_OVER["Iron Overload"]

    subgraph Synaptic["Synaptic Consequences"]
        LOW_ZN["Low Synaptic Zinc"]
        SHANK["SHANK Protein Dysfunction"]
        NMDA["NMDA Receptor Dysregulation"]
        EI["E/I Imbalance"]
        ASD["Autism-Relevant Effects"]
    end

    FE_OVER --> DMT1
    FE_OVER --> ZIP
    DMT1 --> FE_IN
    DMT1 -.-> ZN_IN
    ZIP --> FE_IN
    ZIP -.-> ZN_IN

    ZN_IN -.-> LOW_ZN
    LOW_ZN --> SHANK --> NMDA --> EI --> ASD

    classDef overload fill:#f1948a,stroke:#c0392b,color:#1a0505
    classDef transport fill:#58d68d,stroke:#1e8449,color:#0a1f12
    classDef consequence fill:#f7dc6f,stroke:#b7950b,color:#1a1400

    class FE_OVER overload
    class DMT1,ZIP,FE_IN,ZN_IN transport
    class LOW_ZN,SHANK,NMDA,EI,ASD consequence

Beyond Gut Absorption

The Copper-Zinc-Iron Interactions note covers intestinal absorption competition. This note focuses on brain-level zinc-iron interactions — including transport, neurotransmitter modulation, and direct relevance to autism and ADHD.

Transport Overlap in the Brain

DMT1 in the Brain

Garrick MD et al. "Iron, copper, and zinc transport: inhibition of DMT1 and hCTR1 by shRNA." Biometals. 2012;25(6):1177-1184. PMID: 22068728

ZIP Transporters

Bowers K, Bhatt DK et al. "Current understanding of ZIP and ZnT zinc transporters in human health and diseases." Cell Mol Life Sci. 2024;81:241. PMC11113243

ZnT Transporters

ZnT family (SLC30A): exports zinc from the cytosol

The Competition at the BBB

Yokel RA. New evidence of iron and zinc interplay at the enterocyte and neural tissues. J Nutr. 2006;136(4):1126-1127

Synaptic Zinc — The Hidden Neurotransmitter

Zinc is co-released with glutamate from excitatory synapses and acts as a neuromodulator. This is entirely distinct from its enzymatic roles.

McAllister BB, Bhatt DK et al. "Zinc transporter 3 (ZnT3) and vesicular zinc in central nervous system function." Neurosci Biobehav Rev. 2017;80:329-350

Zinc Modulation of NMDA Receptors

Anderson CT et al. "Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc." PNAS. 2015;112(20):E2705-E2714. PMC4443361

Medvedeva YV et al. "Synaptic zinc inhibition of NMDA receptors depends on the association of GluN2A with the zinc transporter ZnT1." Sci Adv. 2020;6(27):eabb1515. PMC7458442

Zinc, NMDA Receptors, and Autism

Nishito Y et al. "The role of zinc and NMDA receptors in autism spectrum disorders." Pharmaceuticals. 2023;16(1):1. PMC9866730

The SHANK-Zinc-NMDAR Axis

Zinc released from presynaptic terminal
        |
        v
Inhibits GluN2A-NMDAR (prevents overexcitation)
        |
        v
Also promotes SHANK2/SHANK3 recruitment to PSD
        |
        v
SHANK proteins stabilise NMDAR and AMPAR at synapse
        |
        v
Proper excitatory synapse function

If zinc is depleted (due to iron competition):

Iron Overload -> Zinc Depletion -> Autism Worsening

For HFE carriers with iron overload and autism:

  1. Systemic iron overload suppresses zinc absorption (gut competition via DMT1)
  2. Low systemic zinc (12.5 umol/L, 12% into range) means less zinc delivered to the brain
  3. At the BBB, iron-loaded ZIP8/ZIP14 transporters may further reduce zinc entry
  4. In synapses, reduced vesicular zinc means:
    • Less NMDA receptor inhibition -> more excitotoxicity (connects to Iron Glutamate and Excitotoxicity)
    • Less SHANK protein stabilisation -> synapse dysfunction
    • Worsened E/I imbalance -> worsened autism symptoms
  5. Iron also directly increases glutamate release via System Xc- -> double hit on excitatory signalling

Clinical Implications

  1. Zinc supplementation has evidence in ASD (via SHANK/NMDAR pathway) — but must be timed away from iron-rich meals
  2. Iron reduction (phlebotomy) may naturally improve zinc absorption and brain zinc levels
  3. Erythrocyte zinc is a more reliable measure than serum zinc and should be tested
  4. The combination of low zinc + high iron may be a specific risk signature for worsened autism symptoms
  5. Zinc carnosine or zinc picolinate may have better brain bioavailability than zinc gluconate
  6. Selenium status should also be checked — selenium is required for GPX4 (ferroptosis defence) and some selenoproteins interact with zinc transporters

Cross-References